Qrativ Company

Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical.
Technology: Cancer
Industry: Artificial Intelligence, Biotechnology, Data Processing, Drug Repurposing, Machine Learning, Pharmaceutical
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2017-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 3
Total Funding: 8300000
Estimated Revenue: $1M to $10M
Last Funding Date: 2017-07-14
Last Funding Type: Series A

Visit Website
Register and Claim Ownership